Candriam SCA’s Loxo Oncology, Inc LOXO Stock Holding History

Candriam SCA’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-200,673	Closed	-$28.1M	–	855
2018 Q4	$28.1M	Buy	200,673 +63,131	+46%	+$9.58M	0.43%	49
2018 Q3	$23.5M	Buy	137,542 +63,300	+85%	+$10.6M	0.31%	68
2018 Q2	$12.9M	Buy	74,242 +2,242	+3%	+$337K	0.2%	128
2018 Q1	$8.31M	Sell	72,000 -19,000	-21%	-$2.02M	0.14%	190
2017 Q4	$7.66M	Sell	91,000 -11,400	-11%	-$950K	0.13%	195
2017 Q3	$9.43M	Buy	102,400 +28,400	+38%	+$2.21M	0.16%	166
2017 Q2	$5.93M	Sell	74,000 -29,000	-28%	-$1.61M	0.11%	218
2017 Q1	$4.33M	Buy	103,000 +23,000	+29%	+$947K	0.08%	277
2016 Q4	$2.57M	Buy	+80,000	New	+$2.05M	0.06%	319

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Candriam SCA's LOXO Position: Q1 2019 in Review

Candriam SCA sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 200,673 shares — an estimated $28.1M sold.

Candriam SCA first reported a position in LOXO in Q4 2016 and held it in 9 quarters. The position peaked at $28.1M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Candriam SCA reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Candriam SCA sold 200,673 Loxo Oncology, Inc shares in Q1 2019, an estimated $28.1M.
Candriam SCA first reported a position in Loxo Oncology, Inc in Q4 2016 and held it in 9 quarters.
Candriam SCA's Loxo Oncology, Inc position peaked at $28.1M in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.